Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco, where he is the Holly...
In an effort to increase patient access to innovative investigational medicines, Sanofi will partner with Inato to connect with community-based sites...
Christophe Massard, MD PhD is a medical oncologist and the department head at Drug Development Department (DITEP) in Paris, France. He is a member of...
On Thursday June 18th between 12:00 - 1:00 pm EST, Inato hosted a discussion on how to secure more clinical trials for your site
In alignment with a mission to broaden clinical trial access worldwide, Inato has seen major growth across its network in 2022.
Despite the nationwide incidence rate being lower than that of white women, Black women face a 41% higher death rate accompanying a breast cancer...
Inato Senior DE&I Growth Manager, Atira Goodwin sits down with Greater Gift Director of Community Outreach, Perla Nunes, for a deep dive on how we...
Community-based sites’ untapped patient populations, strong community bonds, and personal patient-physician relationships are the keys to unlocking...
With clinical trial budget negotiation being one of the biggest contributors to lost time during study start-up, a transformation towards efficiency...
To a crowded room of pharma leaders, Inato’s Liz Beatty and Otsuka’s Candace Saldarini presented their teams’ findings on how collaborating with...